CDEK
← All drugs Report issue

fatty acid

Small moleculeexperimental

In biochemistry and nutrition, a polyunsaturated fat is a fat that contains a polyunsaturated fatty acid, which is a subclass of fatty acid characterized by a backbone with two or more carbon–carbon double bonds. Some polyunsaturated fatty acids are essentials. Polyunsaturated fatty acids are precursors to and are derived from polyunsaturated fats, which include drying oils. — Wikipedia

Clinical trial activity

63 trials · 90 clinical orgs · 0 marketing orgs

Phase 1
5
Phase 2
19
Phase 3
12
Phase 4
7

Earliest trial started Sep 1, 1999 (NCT00010842)

Timeline

1990s

  1. Jan 1, 1999

    Earliest Phase 1 Sponsor(trial)

2000s

  1. Jan 1, 2002

    Earliest Phase 3 Sponsor(trial)

  2. Jan 1, 2003

    Earliest Phase 2 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

  • Unspecified targetSupplementation

    supplementation

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • dha-enriched omega-3 polyunsaturated fatty acid
  • epa-enriched omega-3 polyunsaturated fatty acid
  • essential fatty acids
  • fatty acid
  • hyper-oxigenated fatty acid
  • long-chain fatty acids
  • medium chain fatty acid
  • medium-chain fatty acid
  • medium-chain fatty acids
  • medium-chain saturated fatty acids
  • middle-chain fatty acids
  • n-3 pufa
  • n-3 pufa
  • polyunsaturated fatty acid
  • polyunsaturated fatty acids
  • reesterified long-chain n-3 polyunsaturated fatty acids
  • unsaturated fatty acids

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07024238N/AApr 4, 2025Abecma, University Hospital, Martin
NCT06595680Phase 2Jan 1, 2025University of Lyon
NCT06699030N/ADec 1, 2024Hepatopancreatobiliary Surgery Institute of Gansu Province
NCT06686888N/ASep 25, 2024Katholieke Universiteit Leuven
NCT07016763Early Phase 1 (Phase 1)Sep 1, 2024Isola Tiberina - Gemelli Isola Hospital, Rome, Italy
NCT06222294Phase 3Mar 12, 2024Hengrui Therapeutics, Inc.
NCT06951581N/AJan 15, 2024Abecma, University Hospital, Martin
NCT06150261N/ADec 31, 2023University of Stavanger
NCT06082726N/AOct 9, 2023Katholieke Universiteit Leuven
NCT05650294N/AJan 31, 2023Aker Biomarine Antarctic AS, BioTeSys GmbH
NCT04700527Phase 1/Phase 2 (Phase 2)Apr 30, 2022University of North Carolina at Chapel Hill
NCT05267301N/AMar 1, 2022Arizona State University, Qualitas Health
NCT05144646N/AJan 4, 2022University of Malaga
NCT05152615N/ANov 17, 2021New York University
NCT04977778N/ASep 1, 2021University of L'Aquila
NCT04958382N/AAug 10, 2021Sichuan University
NCT05198167N/AJun 12, 2021Autonomous University of Madrid, Universidad Autonoma de Madrid
NCT04743050Phase 3Dec 9, 2020Wroclaw Medical University
NCT04335032Phase 3Apr 13, 2020SLA Pharma
NCT03851120Phase 2Jul 1, 2019Grand Challenges Canada, Indonesian Medical Education Research Institute, University of Indonesia
Showing 20 of 63 trials
Page 1 / 4

Organizations

Research & Development (90)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Osaka UniversityAcademic/Hospital3022007
AbecmaFor profit2012024
B. BraunFor profit2222006
Department of Veteran AffairsGovernment2121999
Katholieke Universiteit LeuvenAcademic/Hospital2212023
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Government2122005
Northumbria UniversityAcademic/Hospital2212007
SLA PharmaFor profit2212018
Universidad Autonoma de MadridAcademic/Hospital2022006
University Hospital, MartinAcademic/Hospital2212024
University of BolognaAcademic/Hospital2122014
University of BresciaAcademic/Hospital2212006
University of OsloAcademic/Hospital2222007
University of RochesterAcademic/Hospital2022006
Aarhus UniversityAcademic/Hospital1112011
Aker Biomarine Antarctic ASFor profit1112023
Akorn, Inc.For profit1012004
Andaluz Health ServiceAcademic/Hospital1112012
Arizona State UniversityAcademic/Hospital1012022
Arla FoodsFor profit1012011
90 organizations
Page 1 / 5